Sonnet BioTherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SONN and other ETFs, options, and stocks.

About SONN

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. 

CEO
Pankaj Mohan
CEOPankaj Mohan
Employees
12
Employees12
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2011
Founded2011
Employees
12
Employees12

SONN Key Statistics

Market cap
5.43M
Market cap5.43M
Price-Earnings ratio
-0.14
Price-Earnings ratio-0.14
Dividend yield
—
Dividend yield—
Average volume
19.16K
Average volume19.16K
High today
$1.80
High today$1.80
Low today
$1.73
Low today$1.73
Open price
$1.77
Open price$1.77
Volume
10.51K
Volume10.51K
52 Week high
$26.40
52 Week high$26.40
52 Week low
$1.08
52 Week low$1.08
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.